Research in CPROR

  • Three ovals stacked: "PROs in Trials", "Applied PROs Research" and "PROs in Routine Practice".

    Our areas of work

    Our latest research spans across three main areas: PROS in trials, Applied Research and Routine Practice.

PROs in trials

CPROR is working with international collaborators to develop best practice for PROs in clinical trials. This includes the selection of PROs, trial design (including the development of a SPIRIT-PRO extension), minimising missing data, managing PRO Alerts and the transparent reporting of PRO data (using CONSORT-PRO) to maximise impact and patient benefit.

Current projects:

Five adjacent columns (left to right): "Selection", "Trial Design", Trial processes", "Reporting", and "Implementation".

Applied PRO research

CPROR members provide methodological expertise across a range of applied health research including:

Bluebelle: a feasibility study of three wound dressing strategies in eLective and unplanned surgery

Pegasus: the feasibility of a full-scale open trial of the effectiveness and cost-effectiveness of pressure garments

Missed Opportunities To Prevent Stroke And Residual Impairments After Transient Ischaemic Attack (TIA)

Optimising rate-control therapy in older patients with AF– a training fellowship and pilot study focused on improving quality of life

NOAH: Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes

RATE-AF: Optimising rate-control therapy in older patients with AF– a training fellowship and pilot study focused on improving quality of life

SUPPORT TIA: Structured follow-Up Pathway to imProve management Of Residual impairmenTs and patients’ quality of life after TIA and minor stroke. Development and feasibility testing of a care pathway that will help manage long-term problems after mini-stroke

PRiORiTy: Patient Reported Outcomes Research in Trauma. Developing a pathway for the electronic capture of PROMs/PREMs for inclusion within the SRMRC clinical information platform for use in research and routine and ongoing clinical care

PRO-CAR-T™ Study. 

CAR-T therapy is a new approach to cancer treatment in which the body's own immune cells are modified to recognise and kill off cancer cells. CAR-T therapy is promising but the side effects of treatment can be serious. It is important to catch side effects early so people can receive medicines to help treat them. One way of monitoring side effects is to ask patients to report their symptoms. Digital tools to assess CAR-T patients’ symptoms are not yet widely available. We are conducting the PRO-CAR-T™ research study to develop and test a new digital tool specifically designed to collect patients’ symptom and quality of life data reports following CAR-T therapy.

Milestone 1 - Intervention development:

  • Literature review of construct domains and candidate PROs.
  • Participants invited to select PROs for inclusion in the ePRO intervention.
  • Participants invited to co-design ePRO intervention, including clinical alert functionality.

Milestone 2 - Usability testing:

  • Build ePRO intervention in the Aparito Atom5 platform
  • Participants invited to test the usability of the ePRO intervention.

Milestone 3 - Establish feasibility in real-world settings:

  • Explore feasibility in 
    1.  acute clinical settings
    2. for longer term, remote patient monitoring.
  • Results inform design of a future, definitive RCT of intervention effectiveness.

This work is funded by the NIHR Blood and Transplant Research Unit in Precision and Cellular Therapeutics. For further information please contact: btru@contacts.bham.ac.uk

The PRO-CAR-T™ Study overview (more information above).

Routine practice

International research in cancer has shown that ePROs can:

  • Improve communication between patients and doctors, helping shared decision-making
  • Improve patient quality of life
  • Reduce the risk of hospital admission
  • Increase patient survival

CPROR members are leading research to develop ePRO systems that tailor care to individual patient needs, improve care and outcomes including: